A detailed history of Inspire Trust Co, N.A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Inspire Trust Co, N.A. holds 103,500 shares of BMY stock, worth $5.93 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares
103,500
Previous 74,456 39.01%
Holding current value
$5.93 Million
Previous $3.09 Billion 73.18%
% of portfolio
1.47%
Previous 1.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 02, 2024

BUY
$39.66 - $51.75 $1.15 Million - $1.5 Million
29,044 Added 39.01%
103,500 $5.36 Billion
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $817,678 - $1.08 Million
20,315 Added 37.52%
74,456 $3.09 Billion
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $1.19 Million - $1.35 Million
24,805 Added 84.55%
54,141 $2.94 Billion
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $1.42 Million - $1.7 Million
29,336 New
29,336 $1.51 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Inspire Trust Co, N.A. Portfolio

Follow Inspire Trust Co, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Trust Co, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Inspire Trust Co, N.A. with notifications on news.